Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NBIX
NBIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBIX News
Biotech Sector Sees FDA Approvals and Layoffs
2d ago
NASDAQ.COM
Long-Term Efficacy of VYKAT XR for Prader-Willi Syndrome
5d ago
PRnewswire
Neurocrine Biosciences Reveals Clinical Findings on CAH Treatment
5d ago
PRnewswire
CRENESSITY Shows Significant Clinical Effects in Patients with 11β-Hydroxylase Deficiency
5d ago
Newsfilter
Long-Term Efficacy of VYKAT XR in Treating Prader-Willi Syndrome
5d ago
Newsfilter
Neurocrine Reports Positive Two-Year Data for Crenessity in Pediatric CAH Study
5d ago
NASDAQ.COM
Neurocrine Reports Positive Data from CAH Study
5d ago
PRnewswire
Neurocrine Releases New Phase 3 Data on CRENESSITY for CAH
5d ago
PRnewswire
Positive Growth Outcomes from CRENESSITY Treatment in Pediatric CAH Patients
5d ago
Newsfilter
Neurocrine Releases New Ingrezza Data for Tardive Dyskinesia
Jun 09 2026
NASDAQ.COM
Neurocrine Biosciences Reveals New INGREZZA Data at Psych Congress
Jun 08 2026
PRnewswire
Neurocrine Reports New INGREZZA Data for Tardive Dyskinesia
Jun 08 2026
PRnewswire
INGREZZA Shows Rapid Improvement in Tardive Dyskinesia for Patients with Intellectual Disabilities
Jun 08 2026
Newsfilter
Broadcom and CrowdStrike Shares Drop Post Earnings
Jun 04 2026
Yahoo Finance
Wednesday ETF Component Trading Dynamics
Jun 03 2026
NASDAQ.COM
Global X Uranium ETF Underperforms
Jun 03 2026
NASDAQ.COM
Show More News
